Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma

Selective Laser Trabeculoplasty (SLT) is known to reduce intraocular pressure in glaucoma patients. This study investigates, if there are changes in different ocular hemodynamic parameters prior and after SLT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Eye Clinic Dresden

Dresden, Saxony, 01307, Germany

About this study

Ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.) prior and 3 month after SLT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

glaucoma patient
over 18 years
needs further intraocular pressure regulation

Exclusion criteria

age under 18 years
debilitated
no glaucoma

Treatment and study plan

Selective Laser Trabeculoplasty

Procedure

360° selective laser trabeculoplasty, 100 non-overlapping spots, energy 0,5-1,2 mJ

Other names: Lasertrabeculoplasty

Primary outcomes

Change in ocular hemodynamics after Selective Laser Trabeculoplasty (SLT)

Time frame: baseline and 3 month

Pulsatile ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured prior and 3 month after SLT with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.)

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Technische Universität Dresden

Other

Registry information

Official study title

Effect of Selective Lasertrabeculoplasty (SLT) on Ocular Hemodynamics in Glaucoma

Acronym: SLT/OBF

Important dates

Study start: 2010
Primary completion: 2011
Study completion: 2011
First posted: Jun 1, 2011
Registry last updated: Dec 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed